PHX stock hits 52-week high at $4.18 amid robust annual growth
Panhandle Royalty Company (PHX) stock soared to a 52-week high, reaching $4.18, as investors rallied behind the company's strong performance over the past year. With a market capitalization of $152.36 ...
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Cathie Wood’s ARK Makes Big Trades. Sells PLTR and Hood but Buys SHOP, AMD, TSM, and AMZN
Cathie Wood’s ARK line of ETFs made some significant trades yesterday, selling Palantir Technologies (PLTR) and Robinhood ...
Needham & Company LLC Lowers Pliant Therapeutics (NASDAQ:PLRX) Price Target to $10.00
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) had its price target lowered by equities researchers at Needham & Company LLC from $38.00 to $10.00 in a report released on Monday,Benzinga reports.
Canaccord Genuity Group Reiterates Hold Rating for Pliant Therapeutics (NASDAQ:PLRX)
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “hold” rating restated by research analysts at Canaccord Genuity Group in a note issued to investors on Monday, MarketBeat reports.